PLoS ONE · 2009 · 98 citations · 1 references
Social SciencesGeographyHuman GeographyClimate Change AdaptationCommunity ResiliencePacific Islander StudiesClimate VulnerabilityNatural HazardsOceanic SettlementPacific GovernanceResilience GovernanceSocial VulnerabilityThreatened Island Fauna
The drug development pipeline for LSDs is growing and evolving, with increased focus on diverse small-molecule targets and gene therapy. CLN2 was the first and only LSD with an approved therapy directly targeted to the brain. Newly approved products included "me-too"-enzymes and innovative compounds such as the first pharmacological chaperone for the treatment of Fabry disease.
1
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Ernesto R. Bongarzone, Maria L. Escolar, Steven J. Gray et al. · PubMed · 2016 · 33 citations
Medicine, Neurology, Neuroscience +17